| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hare Joshua | Chief Scientific Officer, Director, 10%+ Owner | 1951 NW 7TH AVENUE, SUITE 520, MIAMI | /s/ Paul T. Lehr, attorney-in-fact | 2025-05-16 | 0001449392 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LGVN | Class A Common Stock | Sale | -$7.37K | -5.25K | -0.72% | $1.40 | 722K | May 16, 2025 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.42, inclusive. The reporting person undertakes to provide to Longeveron Inc., any security holder of Longeveron Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. |
| F2 | Includes RSUs subject to future vesting. |
| F3 | Amount includes 462,807 shares of Class B common stock, which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B common stock have identical rights to holders of common stock, except that holders of Class B common stock are entitled to 5 votes for each share held of record. Each share of Class B common stock is convertible at any time, at the option of the holder, into one share of common stock. |